{"url_path":"/sec/avai/10-k/2026/item-9b","section_key":"item-9b","section_title":"Item 9B Other Information.**","topic":"sec","document":{"doc_type":"10-K","doc_date":"2026-07-14","source_url":"https://www.sec.gov/Archives/edgar/data/1740797/0001740797-26-000017-index.html","accession_number":"0001740797-26-000017","cik":"0001740797","ticker":"AVAI","issuer_name":"AVAI BIO, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1740797/0001740797-26-000017-index.html","primary_entity_key":"0001740797","primary_entity_name":"AVAI BIO, INC."},"word_count":43,"has_tables":true,"body_markdown":"**Item 9B. Other Information.**\n\n \n\nNone of our directors or executive officers adopted\nor terminated a Rule 10b5-1 trading arrangement or adopted or terminated a non-Rule 10b5-1 trading arrangement (as defined in Item 408(c)\nof Regulation S-K) during the year ended March 31, 2026."}